The lower prevalence of muscle atrophy of anti-SRP IMNM overlap SS group prompted us to determine whether the histopathological features of patients with anti-SRP IMNM overlap SS were distinct from those with anti-SRP IMNM. This evidence concerns the gene UCN2 and synovial sarcoma.